AAIPharma Completes Acquisition of CAC and Launches New AAIOncology Business Unit.WILMINGTON, N.C. -- AAIPharma Inc. announced today that it has completed the previously announced acquisition of Cvitkovic & AssociE[umlaut umlaut (  m`lout) [Ger.,=transformed sound], in inflection, variation of vowels of the type of English man to men. ]s Consultants S.A. (CAC See Consumer Advisory Council. ), an international contract research organization specializing in oncology oncology /on·col·o·gy/ (ong-kol´ah-je) the sum of knowledge regarding tumors; the study of tumors. on·col·o·gy n. drug development and medical consulting. CAC has clinical operations in France, Croatia, Russia, Spain, Argentina, Peru, and the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. . As a result of the acquisition, CAC has become the foundation of AAIOncology, a global business unit dedicated to oncology drug development. "We are very pleased to have completed the acquisition of CAC, and we welcome our new colleagues to AAIPharma," said John Hall, Ph.D., AAIPharma president of European operations. "CAC's approach over the years has been to provide a unique combination of medical expertise and execution excellence in the area of oncology drug development. At AAIPharma, CAC's patient-centric medical approach will serve as the model for the development of other therapeutic business units in areas of unmet need." "AAIOncology will significantly strengthen our presence and impact in oncology drug development worldwide," said Vito Mangiardi, AAIPharma president of North American operations North American operation Surgical oncology Radical surgery of a 'frozen pelvis', consisting of radical en bloc resection of the uterus and urinary bladder. See 'Frozen pelvis.'. Cf 'All-American' and 'South American' operations. . "The experience and expertise brought by our new colleagues in the area of early clinical development in oncology will significantly strengthen our company's ability to execute large and global late-stage clinical development programs." "We are privileged to become part of AAIPharma given the strength and reputation of its people and services," said Scott Spector, CAC CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "AAIPharma's operations platform across the whole drug development process will help us provide an ever-broader and more significant contribution to the development programs of our customers worldwide. We believe the combination of CAC and AAIPharma will provide a new and expanded model for delivering oncology drug development." About AAIPharma AAIPharma Inc. is a global provider of product development and support services support services Psychology Non-health care-related ancillary services–eg, transportation, financial aid, support groups, homemaker services, respite services, and other services to the pharmaceutical, biotechnology and medical device industries. From a single test through a range of integrated service offerings, we create value to an industry in search of productivity and innovation. For more information on the Company, please visit AAIPharma's website at www.aaipharma.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion